@article{81332d650d0e4417b6f6f15b081c289a,
title = "The Enduring Legacy of Failed Revascularization Trials",
keywords = "clinical trial, coronary artery disease, pressure wire",
author = "Dauerman, {Harold L.} and Tijssen, {Jan G. P.} and Gilles Montalescot",
note = "Funding Information: Dr Dauerman has served as a consultant for and received research grant support from Medtronic and Boston Scientific. Dr Montalescot has received institutional research funds or fees from Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cell Prothera, CSL Behring, Europa, Idorsia, IRIS-Servier, Medtronic, MSD, Novartis, Pfizer, Quantum Genomics, and Sanofi. Dr Tijssen has reported that he has no relationships relevant to the contents of this paper to disclose.",
year = "2021",
month = nov,
day = "9",
doi = "https://doi.org/10.1016/j.jacc.2021.08.059",
language = "English",
volume = "78",
pages = "1886--1889",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "19",
}